Lord, Abbett & Co’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HEC
FLAM
PCM
Lord, Abbett & Co's ATRC Position: Q1 2018 in Review
Lord, Abbett & Co sold out of AtriCure (ATRC) in Q1 2018, closing a stake of 245,653 shares — an estimated $4.48M sold.
Lord, Abbett & Co first reported a position in ATRC in Q1 2014 and held it in 11 quarters. The position peaked at $11.2M in Q2 2015. 108 funds tracked by Wall St. Rank hold ATRC as of Q1 2018.
- Lord, Abbett & Co reported no remaining AtriCure position as of Q1 2018 after selling out during the quarter.
- Lord, Abbett & Co sold 245,653 AtriCure shares in Q1 2018, an estimated $4.48M.
- Lord, Abbett & Co first reported a position in AtriCure in Q1 2014 and held it in 11 quarters.
- Lord, Abbett & Co's AtriCure position peaked at $11.2M in Q2 2015.
- 108 funds tracked by Wall St. Rank held AtriCure as of Q1 2018.
Based on Lord, Abbett & Co's 13F filing for Q1 2018, filed 15 May 2018.